QEP Resources (QEP) Reaches $8.87 After 5.00% Down Move; SkyePharma PLC (LON:SKP) Covered By 4 Bulls

June 20, 2017 - By Kurt Siggers

The stock of QEP Resources Inc (NYSE:QEP) is a huge mover today! About 581,971 shares traded. QEP Resources Inc (NYSE:QEP) has declined 34.57% since June 20, 2016 and is downtrending. It has underperformed by 51.27% the S&P500.The move comes after 8 months negative chart setup for the $2.19B company. It was reported on Jun, 20 by Barchart.com. We have $8.43 PT which if reached, will make NYSE:QEP worth $109.50M less.

Among 4 analysts covering SkyePharma PLC (LON:SKP), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. SkyePharma PLC had 22 analyst reports since July 30, 2015 according to SRatingsIntel. The firm has “Buy” rating by Stifel Nicolaus given on Friday, January 8. The stock of SkyePharma PLC (LON:SKP) earned “Buy” rating by RX Securities on Wednesday, December 23. On Wednesday, December 16 the stock rating was maintained by N+1 Singer with “Corporate”. The firm earned “Corporate” rating on Wednesday, August 26 by N+1 Singer. On Thursday, November 26 the stock rating was maintained by FinnCap with “Hold”. FinnCap maintained SkyePharma PLC (LON:SKP) on Friday, January 22 with “Buy” rating. The company was maintained on Wednesday, February 17 by Stifel Nicolaus. The stock of SkyePharma PLC (LON:SKP) earned “Buy” rating by Stifel Nicolaus on Thursday, January 28. On Friday, January 8 the stock rating was maintained by N+1 Singer with “Corporate”. The firm has “Corporate” rating by N+1 Singer given on Wednesday, December 23. See SkyePharma PLC (LON:SKP) latest ratings:

It is down 0.00% since June 20, 2016 and is . It has underperformed by 16.70% the S&P500.

Skyepharma Ltd, formerly Skyepharma PLC, is a drug delivery firm engaged in the development of oral and inhalation products. The company has market cap of 470.25 million GBP. The Firm operates as an independent developer of complex pharmaceutical products for global markets. It has a 18.1 P/E ratio. The Company’s principal activities are the generation and development of product and drug delivery technology concepts, involving the application of its inhalation and oral technologies.

Analysts await QEP Resources Inc (NYSE:QEP) to report earnings on July, 26. They expect $-0.19 EPS, up 17.39% or $0.04 from last year’s $-0.23 per share. After $-0.14 actual EPS reported by QEP Resources Inc for the previous quarter, Wall Street now forecasts 35.71% negative EPS growth.

Since February 24, 2017, it had 1 buying transaction, and 0 selling transactions for $99,470 activity. 7,000 shares were bought by BAKER PHILLIPS S JR, worth $99,470.

QEP Resources, Inc. is an independent natural gas and crude oil exploration and production company. The company has market cap of $2.19 billion. The Firm focuses on two regions of the United States: the Northern Region and the Southern Region (primarily in Texas and Louisiana). It currently has negative earnings. The Firm conducts exploration and production activities in North America’s hydrocarbon resource plays.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: